跳至主要内容
临床试验/IRCT2013072710325N2
IRCT2013072710325N2已完成未知

The effect of probiotic supplementation on patients' Hemoglobin with chronic Renal failure on Hemodialysis,

Deputy of Research andTechnology, Golestan University0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 80 years(—)
性别
All

入选标准

  • Over 17 years old;
  • Both sexess;
  • Erythropoietin therapy for at least 4 weeks;
  • Hemodialysis treatment for at least 6 months;
  • 3 times dialysis per week and 4 hours per session;
  • Hemoglobin concentration <11g/dL in at least 3 episode;
  • CRP more than 10 mg/ lit;
  • No sever hyperparathyroidism;
  • No surgery or bleeding in the last 3 months;
  • Lack of Hemoglobin disorder including: Thalassemia or Sickle cell anemia;
  • Lack of iron deficiency;
  • Lack of folate and vitamin B12 deficiency;
  • Absence of active infection;
  • Lack of immune disorders such as Lupus erythematosus;
  • Absence of malignancy;
  • No Alcohol consuming;
  • No Consumption antibiotics in 10 days ago;
  • No Consumption corticosteroids;
  • Lack of viral infections: AIDS;
  • No Hospitalization;
  • Exclusion criteria:
  • Antibiotic therapy during the study;
  • Hospitalization;
  • Blood transfusion during the study;
  • Surgery during the study;
  • Change in drug program that it is effective on the anemia;
  • Change in dialysis program;
  • No Patient's tendency to stay in study;
  • Malignancy diagnosis during the study;
  • The presence of bleeding disorders during the study;

排除标准

  • 未提供

研究者

发起方
Deputy of Research andTechnology, Golestan University

相似试验